British Journal of Oral and Maxillofacial Surgery
Volume 47, Issue 4 , Pages 302-305 , June 2009

Craniomaxillofacial fibrous dysplasia: A 10-year database 1996–2006

  • A. Kruse

      Affiliations

    • Department of Craniomaxillofacial and Oral Surgery, University Hospital Zurich, Frauenklinikstr. 24, CH-8091 Zürich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 44 2551111; fax: +41 44 2554179.
    • ,
  • U. Pieles

      Affiliations

    • University of Applied Sciences Northwestern Switzerland, Gründerstr. 40, CH-4132 Muttenz, Switzerland
    • ,
  • M.O. Riener

      Affiliations

    • Department of Pathology, University Hospital Zurich, Frauenklinikstr. 24, CH-8091 Zürich, Switzerland
    • ,
  • Ch. Zunker

      Affiliations

    • Department of Craniomaxillofacial and Oral Surgery, University Hospital Zurich, Frauenklinikstr. 24, CH-8091 Zürich, Switzerland
    • ,
  • M.G. Bredell

      Affiliations

    • Department of Craniomaxillofacial and Oral Surgery, University Hospital Zurich, Frauenklinikstr. 24, CH-8091 Zürich, Switzerland
    • ,
  • K.W. Grätz

      Affiliations

    • Department of Craniomaxillofacial and Oral Surgery, University Hospital Zurich, Frauenklinikstr. 24, CH-8091 Zürich, Switzerland

,Accepted 19 January 2009.

References 

  1. Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg. 1938;36:874–898
  2. Yamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M, et al. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest. 1996;98(1):30–35
  3. Corsi A, Collins MT, Riminucci M, Howell PG, Boyde A, Robey PG, et al. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. J Bone Miner Res. 2003;18(7):1235–1246
  4. Weinstein LS. G(s)alpha mutations in fibrous dysplasia and McCune–Albright syndrome. J Bone Miner Res. 2006;21(Suppl. 2):P120–P124
  5. Edgerton MT, Persing JA, Jane JA. The surgical treatment of fibrous dysplasia. With emphasis on recent contributions from cranio-maxillo-facial surgery. Ann Surg. 1985;202:459–479
  6. Yabut SM, Kenan S, Sissons HA, Lewis MM. Malignant transformation of fibrous dysplasia. A case report and review of the literature. Clin Orthop Relat Res. 1988;(228):281–289
  7. Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med. 1937;216:727–746
  8. Hoshi M, Matsumoto S, Manabe J, Tanizawa T, Shigemitsu T, Izawa N, et al. Malignant change secondary to fibrous dysplasia. Int J Clin Oncol. 2006;11(3):229–235
  9. Fries JW. The roentgen features of fibrous dysplasia of the skull and facial bones; a critical analysis of thirty-nine pathologically proved cases. Am J Roentgenol Radium Ther Nucl Med. 1957;77:71–88
  10. Jackson IT, Hide TA, Gomuwka PK, Laws ER, Langford K. Treatment of cranio-orbital fibrous dysplasia. J Maxillofac Surg. 1982;10:138–141
  11. Tehranzadeh J, Fung Y, Donohue M, Anavim A, Pribram HW. Computed tomography of Paget disease of the skull versus fibrous dysplasia. Skeletal Radiol. 1998;27:664–672
  12. Maki M, Saitoh K, Horiuchi H, Morohoshi T, Fukayama M, Machinami R. Comparative study of fibrous dysplasia and osteofibrous dysplasia: histopathological, immunohistochemical, argyrophilic nucleolar organizer region and DNA ploidy analysis. Pathol Int. 2001;51:603–611
  13. Lane JM, Khan SN, O’Connor WJ, Nydick M, Hommen JP, Schneider R, et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res. 2001;(382):6–12
  14. Chapurlat RD. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res. 2006;21(Suppl 2):P114–P119
  15. Yasuoka T, Takagi N, Hatakeyama D, Yokoyama K. Fibrous dysplasia in the maxilla: possible mechanism of bone remodeling by calcitonin treatment. Oral Oncol. 2003;39:301–305
  16. Long A, Loughlin T, Towers RP, McKenna TJ. Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications. Ir J Med Sci. 1988;157:229–234
  17. Bell NH, Avery S, Johnston CC. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia. J Clin Endocrinol Metab. 1970;31:283–290
  18. Ricalde P, Horswell BB. Craniofacial fibrous dysplasia of the fronto-orbital region: a case series and literature review. J Oral Maxillofac Surg. 2001;59:157–168
  19. Goisis M, Biglioli F, Guareschi M, Frigerio A, Mortini P. Fibrous dysplasia of the orbital region: current clinical perspectives in ophthalmology and cranio-maxillofacial surgery. Ophthal Plast Reconstr Surg. 2006;22:383–387
  20. Bland LI, Marchese MJ, McDonald JV. Acute monocular blindness secondary to fibrous dysplasia of the skull: a case report. Ann Ophthalmol. 1992;24:263–266
  21. Chen YR, Noordhoff MS. Treatment of craniomaxillofacial fibrous dysplasia: how early and how extensive?. Plast Reconstr Surg. 1991;87:799–800
  22. Yeow VK, Chen YR. Orthognathic surgery in craniomaxillofacial fibrous dysplasia. J Craniofac Surg. 1999;10:155–159
  23. Schwartz DT, Alpert M. The malignant transformation of fibrous dysplasia. Am J Med Sci. 1964;247:1–20

PII: S0266-4356(09)00030-8

doi: 10.1016/j.bjoms.2009.01.008

British Journal of Oral and Maxillofacial Surgery
Volume 47, Issue 4 , Pages 302-305 , June 2009

Article Tools

* Image Usage & Resolution